<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-TWUYMFHD</identifier><date>2009</date><creator>Obreza, Aleš</creator><relation>documents/doc/T/URN_NBN_SI_doc-TWUYMFHD_001.htm</relation><relation>documents/doc/T/URN_NBN_SI_doc-TWUYMFHD_001.pdf</relation><relation>documents/doc/T/URN_NBN_SI_doc-TWUYMFHD_001.txt</relation><format format_type="issue">2</format><format format_type="volume">60</format><format format_type="type">article</format><format format_type="extent">str. 48-60</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">2554993</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-TWUYMFHD</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">citostatiki</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">umetne snovi</subject><title>Sintezne zdravilne učinkovine v onkologiji</title><title>Synthetic drugs in oncology</title></Record>